Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose inhaled fluticasone versus oral dexamethasone for asthma exacerbations
ACTRN12605000627651Phase 4Recruiting
- Sponsor
- Mater
- Start
- Apr 2003
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone, dexamethasone and prednisolone in asthma (2 arms), sponsored by Mater. Primary endpoints: Achieved peak expiratory flow after treatment, Difference in achieved peak expiratory flow between treatment arms and 1 more. Started Apr 2003; status: recruiting.
02
Drugs
fluticasonedexamethasoneprednisolone
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12605000627651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000627651.